Hims & Hers Health (HIMS) Non-Current Deffered Revenue (2019 - 2021)
Hims & Hers Health (HIMS) reported Non-Current Deffered Revenue of $384000.0 for Q1 2021, down 94.55% on a YoY basis from $7.0 million in Q1 2020, and up 0.79% sequentially from $381000.0 in Q4 2020.
Hims & Hers Health (HIMS) Non-Current Deffered Revenue (2019 - 2021) Analysis & Trends
Hims & Hers Health (HIMS) has 3 years of Non-Current Deffered Revenue data on file, last reported at $384000.0 in Q1 2021.
- For the quarter ending Q1 2021, Non-Current Deffered Revenue fell 94.55% year-over-year to $384000.0; the trailing twelve-month figure through Mar 2021 stood at $384000.0 (down 94.55% YoY), and the FY2020 full-year result was $381000.0, down 94.59% from the prior year.
- Non-Current Deffered Revenue improved to $384000.0 in Q1 2021, from $381000.0 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $7.0 million in Q3 2019 to a low of $381000.0 in Q4 2020.
- A 3-year average of $5.1 million and a median of $7.0 million in 2019 frame the typical range for Non-Current Deffered Revenue.
- Peak annual rise in Non-Current Deffered Revenue reached 0.0% in 2020, while the deepest fall reached 94.59% in 2020.
- Tracing HIMS's Non-Current Deffered Revenue over 3 years: stood at $7.0 million in 2019, then sank by 94.59% to $381000.0 in 2020, then rose by 0.79% to $384000.0 in 2021.
- Business Quant data shows HIMS's Non-Current Deffered Revenue at $384000.0 in Q1 2021, $381000.0 in Q4 2020, and $7.0 million in Q3 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | - |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 384,000.00 |
| Dec 31, 2020 | 381,000.00 |
| Sep 30, 2020 | 7.04 Mn |
| Jun 30, 2020 | 7.04 Mn |
| Mar 31, 2020 | 7.04 Mn |
| Dec 31, 2019 | 7.04 Mn |
| Sep 30, 2019 | 7.04 Mn |